Stockscreener 앱 받기
0.67
0.01%
-0.000100
전일 마감가:
$0.6701
열려 있는:
$0.6882
하루 거래량:
495.41K
Relative Volume:
0.39
시가총액:
$4.28M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-16.25%
1개월 성능:
-56.21%
6개월 성능:
-87.14%
1년 성능:
-95.25%
1일 변동 폭
$0.6147
$0.69
1주일 범위
$0.6147
$0.83
52주 변동 폭
$0.6147
$17.37
Psyence Biomedical Ltd Stock (PBM) Company Profile
PBM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
0.67 | 4.28M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Psyence Biomedical Ltd 주식(PBM)의 최신 뉴스
Entry Recap: Will Psyence Biomedical Ltd benefit from rate cutsWeekly Loss Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Aug Technicals: Is Psyence Biomedical Ltd a top pick in the sectorJuly 2025 Reactions & Smart Money Movement Tracker - baoquankhu1.vn
Quarterly Recap: Whats the beta of Psyence Biomedical Ltd stockGap Down & Daily Technical Forecast Reports - baoquankhu1.vn
Psyence Biomedical Shares Set to Reverse Split on Tuesday, January 20th (NASDAQ:PBM) - Defense World
Breakout Move: Can LSI Industries Inc. benefit from deglobalizationPortfolio Gains Summary & Safe Capital Growth Tips - baoquankhu1.vn
Psyence Biomedical sets Jan. 20 as effective date for reverse stock split - MSN
Psyence BioMed Sets January 20, 2026 Start Date for 1-for-6.25 Reverse Stock Split - TipRanks
Psyence Biomedical (PBM) Announces 1-for-6.25 Reverse Stock Split Effective January 20, 2026 - Intellectia AI
Psyence Biomedical announces 1-for-6.25 share consolidation By Investing.com - Investing.com Nigeria
1-for-6.25 split leaves Psyence BioMed with 1,022,177 shares outstanding - Stock Titan
Psyence Biomedical Ltd. Announces 1-for-6.25 Share Consolidation Effective January 20, 2026 - Quiver Quantitative
Aug Catalysts: Can Psyence Biomedical Ltd Equity Warrant outperform in the next rally2025 Support & Resistance & Precise Swing Trade Alerts - baoquankhu1.vn
PBMPsyence Biomedical Ltd. Latest Stock News & Market Updates - Stock Titan
Psyence Biomedical Board Backs 2026 Strategy and Potential Share Buyback Program - TipRanks
Psyence Biomedical Ltd. (NASDAQ:PBM) Short Interest Down 63.6% in December - Defense World
Why Psyence BioMed may buy its own shares while developing therapies - Stock Titan
How Psyence Biomedical Ltd. stock performs in weak economyJuly 2025 Selloffs & Risk Adjusted Buy and Sell Alerts - Улправда
What is the fair value of Psyence Biomedical Ltd. stock nowFit and Size Notes & lightweight options for faster days - ulpravda.ru
Comparing Compugen (NASDAQ:CGEN) & Psyence Biomedical (NASDAQ:PBM) - Defense World
Is Psyence Biomedical Ltd. stock attractive for hedge fundsWeekly Trade Report & Expert Curated Trade Setup Alerts - ulpravda.ru
Surprises Report: Will Psyence Biomedical Ltd. Equity Warrant stock gain from strong economyJuly 2025 Breakouts & Daily Price Action Insights - Улправда
Will Psyence Biomedical Ltd. stock benefit from infrastructure spendingJuly 2025 PostEarnings & Reliable Breakout Forecasts - Улправда
Why Psyence Biomedical Ltd. stock could benefit from AI revolutionWeekly Stock Summary & Daily Growth Stock Tips - Улправда
What valuation multiples suggest for Psyence Biomedical Ltd. Equity Warrant stockQuarterly Investment Review & Reliable Intraday Trade Alerts - ulpravda.ru
Psyence Biomedical Calls January 22, 2026 Shareholder Meeting to Vote on Financials, Board and Share Consolidation - TipRanks
How currency fluctuations impact Psyence Biomedical Ltd. Equity Warrant stock2025 Trading Volume Trends & Low Volatility Stock Recommendations - ulpravda.ru
Can Psyence Biomedical Ltd. stock rebound after recent weaknessWeekly Trade Report & Reliable Intraday Trade Alerts - Улправда
Will Psyence Biomedical Ltd. Equity Warrant stock deliver consistent dividendsMarket Activity Recap & Weekly Breakout Watchlists - Улправда
Why Psyence Biomedical Ltd. Equity Warrant stock appeals to analystsWeekly Stock Analysis & Expert Verified Stock Movement Alerts - Улправда
How Psyence Biomedical Ltd. stock reacts to oil pricesWeekly Earnings Recap & Technical Confirmation Trade Alerts - Улправда
Psyence Biomedical Ltd.Ordinary Shares (NQ: PBM - FinancialContent
Psyence Biomedical announces milestone in natural ibogaine HCl production - TipRanks
Psyence Biomedical Ltd. Announces Board Changes - marketscreener.com
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash - The Manila Times
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl - GlobeNewswire
A new natural ibogaine source emerges, backed by $12M and no debt - Stock Titan
Published on: 2026-01-04 19:06:08 - earlytimes.in
Investment Recap: Why Psyence Biomedical Ltd Equity Warrant stock appeals to analystsCPI Data & Real-Time Market Sentiment Alerts - Bộ Nội Vụ
Gainers Report: Why Psyence Biomedical Ltd stock could benefit from AI revolutionSell Signal & Real-Time Chart Pattern Alerts - moha.gov.vn
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing - TMX Newsfile
Psyence Biomedical (NASDAQ:PBM) Trading Down 6.1% – Here’s Why - Defense World
Published on: 2025-12-20 18:04:24 - Улправда
Will Psyence Biomedical Ltd. stock benefit from upcoming earnings reportsJuly 2025 Decliners & Technical Buy Zone Confirmations - Улправда
Investment Review: Is Psyence Biomedical Ltd. stock attractive for hedge fundsDay Trade & Safe Capital Growth Plans - moha.gov.vn
Psyence Biomedical’s psilocybin approved for Phase IIb trial use By Investing.com - Investing.com Nigeria
{Company Name} Stock Soars on Exciting Developments - StocksToTrade
Psyence Biomedical stock rises after ethics approval for psilocybin trial By Investing.com - Investing.com South Africa
Psyence Biomedical stock rises after ethics approval for psilocybin trial - Investing.com India
Psyence Biomedical Ltd. Announces Approval for Use of Psylabs' Psilocybin Product in Phase IIb Clinical Trial - MarketScreener
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial - The Manila Times
Psyence BioMed announces approval for use of Psylabs' psilocybin product in phase IIb clinical trial - marketscreener.com
Psyence Biomedical Ltd (PBM) 재무 분석
Psyence Biomedical Ltd (PBM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):